House builder gains stop FTSE falling further

It was somewhat of a mixed day's trading as prices leapt up and down across the main indices. Both AstraZeneca and GlaxoSmithKline lost over 1.5% at the end of Friday trading, as a US consumer watchdog suggested AstraZeneca’s cholesterol drug was too dangerous to sell, and GSK received a ratings downgrade from Citigroup. The FTSE 100 eventually closed down just 0.2% to 4494.1 having earlier in the day lost another 10 points towards 4485 while the FTSE 250 index made a gain of 31.7 points or 0.5% to 6225.6 and the FTSE All-Share ended the day flat at 2238. Interest in the house build...